Rubin M A, Bassily N, Sanda M, Montie J, Strawderman M S, Wojno K
Department of Pathology, Comprehensive Cancer Center, University of Michigan, Ann Arbor 48109-0054, USA.
Am J Surg Pathol. 2000 Feb;24(2):183-9. doi: 10.1097/00000478-200002000-00003.
Serum prostate-specific antigen (PSA) levels and the biopsy Gleason sum are used along with clinical staging to predict prostatectomy pathology results for men with localized prostate cancer. The additional predictive value of perineural invasion (PNI) in pretreatment prostate needle biopsies for evaluating tumor stage in this setting is controversial. The current study evaluates the independent predictive value of PNI for tumor staging in a cohort of 632 men who underwent radical retropubic prostatectomies for clinically localized adenocarcinoma of the prostate between the years 1994 and 1998. None of these men received hormonal or radiation therapy before surgery. In addition to the Gleason sum, biopsy results contained detailed information regarding tumor burden: 1) total number of biopsy cores involved by adenocarcinoma, 2) greatest percentage of any single biopsy involved by prostate carcinoma (GPC), and 3) total percentage of cancer added over all cores (TPC). The presence or absence of any PNI was recorded. Pretreatment factors were analyzed in a univariate and multivariate fashion to determine their predictive value using the TNM tumor stage (pT2 vs pT3) and the modified tumor staging system, which includes surgical margin status (pT2 vs pT3 or positive surgical margin) as end points. Univariate analysis revealed a significant association between pT3 disease and several preoperative factors including age, Gleason sum, serum PSA, digital rectal examination, PNI, GPC, TPC, and the total number of positive cores (p <0.01). Multivariate analysis indicated that serum PSA, Gleason sum, age, and GPC contributed significantly to predicting pT3 disease with odds ratios of 2.7 (95% CI, 1.7-4.3), 2.3 (95% CI, 1.7-3.1), 1.7 (95% CI, 1.1-2.7), and 1.7 (95% CI, 1.4-2.1) respectively. PNI was significant in multivariate analysis only when GPC and TPC were not considered, due to a significant interaction between GPC and PNI (p <0.0001, Wilcoxon's rank sum test). These predictive factors showed a similar relationship to adverse pathology when an alternative definition of adverse pathology was used that included positive surgical margins (pT3 or any positive margin). In the interaction between GPC and PNI, GPC was more significant than PNI in predicting pT3 disease. However, PNI added additional information when adverse pathology was defined more broadly as pT3 or any positive margin.
血清前列腺特异性抗原(PSA)水平和活检Gleason评分与临床分期一起用于预测局限性前列腺癌男性患者的前列腺切除术后病理结果。在这种情况下,前列腺穿刺活检中神经周围浸润(PNI)对评估肿瘤分期的额外预测价值存在争议。本研究评估了1994年至1998年间因临床局限性前列腺腺癌接受根治性耻骨后前列腺切除术的632名男性队列中PNI对肿瘤分期的独立预测价值。这些男性在手术前均未接受激素或放射治疗。除了Gleason评分外,活检结果还包含有关肿瘤负荷的详细信息:1)腺癌累及的活检芯总数,2)任何单个活检中前列腺癌累及的最大百分比(GPC),以及3)所有芯中癌的总百分比(TPC)。记录是否存在任何PNI。采用单因素和多因素分析预处理因素,以TNM肿瘤分期(pT2对pT3)和改良肿瘤分期系统(包括手术切缘状态,以pT2对pT3或阳性手术切缘为终点)确定其预测价值。单因素分析显示pT3疾病与几个术前因素之间存在显著关联,包括年龄、Gleason评分、血清PSA、直肠指检、PNI、GPC、TPC和阳性芯总数(p<0.01)。多因素分析表明,血清PSA、Gleason评分、年龄和GPC对预测pT3疾病有显著贡献,优势比分别为2.7(95%CI,1.7 - 4.3)、2.3(95%CI,1.7 - 3.1)、1.7(95%CI,1.1 - 2.7)和1.7(95%CI,1.4 - 2.1)。由于GPC和PNI之间存在显著相互作用(p<0.0001,Wilcoxon秩和检验),仅在不考虑GPC和TPC时,PNI在多因素分析中才具有显著性。当使用包括阳性手术切缘(pT_{3}或任何阳性切缘)的不良病理替代定义时,这些预测因素与不良病理显示出相似的关系。在GPC和PNI的相互作用中,GPC在预测pT_{3}疾病方面比PNI更显著。然而,当不良病理被更广泛地定义为pT_{3}或任何阳性切缘时,PNI增加了额外信息。